What is it about?
This article looks at obesity-related erectile dysfunction from a different angle. Instead of treating fat tissue as passive extra weight, it argues that dysfunctional fat tissue can actively drive the biology that leads to erectile problems. Fat tissue is not just a storage depot. It releases hormones, inflammatory signals, lipids, extracellular vesicles, and small molecular messages that can affect blood vessels, nerves, hormones, and smooth muscle. In obesity, these signals can become harmful. The review focuses on several fat depots, including visceral fat, perivascular fat, and periprostatic fat. These depots may influence erectile function by reducing nitric oxide availability, increasing inflammation and oxidative stress, damaging the endothelial glycocalyx, altering testosterone-related signaling, and promoting fibrosis in erectile tissue. The main argument is simple: in obesity-related erectile dysfunction, adipose tissue may be an upstream driver, not just a background risk factor.
Featured Image
Photo by Towfiqu barbhuiya on Unsplash
Why is it important?
Erectile dysfunction is often treated as a vascular or hormonal problem, and those mechanisms are important. But this review shows that adipose tissue may sit upstream of many of those problems. This matters because obesity-related erectile dysfunction may begin before severe cardiovascular disease or obvious hormone deficiency appears. Dysfunctional fat tissue can reshape the local and systemic environment through inflammation, senescence, mitochondrial stress, extracellular vesicles, and lipid-mediated injury. The review also highlights why waist size, visceral fat, and fat distribution may be more informative than body weight alone. Two people with similar BMI may have very different adipose biology and therefore different erectile risk. This adipose-centered view may help guide future studies and treatments. Instead of only treating symptoms, future approaches could target adipose inflammation, visceral fat, perivascular fat signaling, senescent cells, extracellular vesicles, or oxidative lipid injury.
Perspectives
This paper was written to challenge a common assumption: that fat tissue is only a secondary contributor to erectile dysfunction. The more interesting possibility is that adipose tissue helps organize the disease process. It can send inflammatory, hormonal, vesicular, oxidative, and metabolic signals that converge on penile blood flow, endothelial function, nerve signaling, and smooth muscle structure. For me, the key message is that erectile dysfunction in obesity should not be viewed only as a downstream complication. It may also be a readout of unhealthy adipose tissue. That shift opens a more precise way to study and potentially treat obesity-related erectile dysfunction.
Ardie Barry Sailis
University of Malaya
Read the Original
This page is a summary of: Adipose as a Driver, Not a Bystander: A Modern Synthesis of Obesity‐Related Erectile Dysfunction, Diabetes Obesity and Metabolism, April 2026, Wiley,
DOI: 10.1111/dom.70818.
You can read the full text:
Resources
Contributors
The following have contributed to this page
